189 Episodes

  1. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom

    Published: 11/20/2020
  2. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France

    Published: 11/19/2020
  3. Molecular Classification of Endometrial Carcinoma in the Clinic Today

    Published: 11/11/2020
  4. Advances in Immunotherapy for Endometrial Cancer

    Published: 11/11/2020
  5. Developments in Acute Leukemias: Expert Answers to Clinician Questions

    Published: 10/2/2020
  6. Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy

    Published: 10/2/2020
  7. Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond

    Published: 10/2/2020
  8. Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC

    Published: 9/21/2020
  9. The Art of Medicine: Clinical Considerations for Patients With Advanced RCC

    Published: 9/21/2020
  10. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

    Published: 9/17/2020
  11. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

    Published: 9/17/2020
  12. Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC

    Published: 9/17/2020
  13. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

    Published: 9/16/2020
  14. CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

    Published: 9/14/2020
  15. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

    Published: 9/8/2020
  16. FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma

    Published: 9/3/2020
  17. New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments

    Published: 9/1/2020
  18. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

    Published: 8/31/2020
  19. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

    Published: 8/31/2020
  20. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

    Published: 8/28/2020

9 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.